Circurna
PrivateLast Round
Seed
Nov 1, 2025
Total Funding Raised
$4.25M
Company Overview
Circurna operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Grant round in January 2024.
Circurna (formerly Emervax) is a biotechnology company developing next-generation vaccines and therapeutics using a proprietary circular RNA platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Circurna Comparables
Compare Circurna with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sail Biomedicines | 85% | |
| CircNova | 85% | |
| Shanghai CirCode Biomed Co. Ltd. | 82% |
For institutional investors. Book with your work email.
Circurna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 1, 2025 | ||||
| Series A | Aug 25, 2025 | ||||
| Grant | Jan 23, 2024 | ||||
| Grant | Oct 24, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Circurna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEPI | Grant |
| Department of Health and Social Care | Grant |
| Innovate UK Contracts for Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Grew 60% QoQ from 5 to 8 employees.
- Jan 22, 2026
Grew 60% QoQ, from 5 to 8 employees.
For institutional investors. Book with your work email.
Circurna Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Circurna's valuation, stock price, and market status.
Is Circurna a public or private company?
Circurna is a private company.
What is the current stock price of Circurna?
Circurna is a private company, so its shares have no public market price. Caplight tracks Circurna's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Circurna worth (valuation)?
Valuation information for Circurna is not publicly available.
Can I buy Circurna stock?
Circurna shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Circurna's last funding round?
Circurna's most recent funding round was Seed on November 1, 2025.
Who are the main investors in Circurna?
Key investors in Circurna include CEPI, Department of Health and Social Care, Innovate UK Contracts for Innovation.
Will Circurna IPO soon?
No public IPO plans have been announced for Circurna.
How can I track Circurna secondary market activity?
Caplight tracks bids, offers, and trades in Circurna's shares on secondary markets.